Login / Signup

Isotopologues of potassium 2,2,2-trifluoroethoxide for applications in positron emission tomography and beyond.

Qunchao ZhaoSanjay TeluSusovan JanaCheryl L MorseVictor W Pike
Published in: Nature communications (2024)
The 2,2,2-trifluoroethoxy group increasingly features in drugs and potential tracers for biomedical imaging with positron emission tomography (PET). Herein, we describe a rapid and transition metal-free conversion of fluoroform with paraformaldehyde into highly reactive potassium 2,2,2-trifluoroethoxide (CF 3 CH 2 OK) and demonstrate robust applications of this synthon in one-pot, two-stage 2,2,2-trifluoroethoxylations of both aromatic and aliphatic precursors. Moreover, we show that these transformations translate easily to fluoroform that has been labeled with either carbon-11 (t 1/2  = 20.4 min) or fluorine-18 (t 1/2  = 109.8 min), so allowing the appendage of complex molecules with a no-carrier-added 11 C- or 18 F- 2,2,2-trifluoroethoxy group. This provides scope to create candidate PET tracers with radioactive and metabolically stable 2,2,2-trifluoroethoxy moieties. We also exemplify syntheses of isotopologues of potassium 2,2,2-trifluoroethoxide and show their utility for stable isotopic labeling which can be of further benefit for drug discovery and development.
Keyphrases
  • positron emission tomography
  • drug discovery
  • computed tomography
  • pet imaging
  • pet ct
  • high resolution
  • cystic fibrosis
  • room temperature
  • human health
  • fluorescence imaging
  • photodynamic therapy